Rv2140c is targeted by follicular helper T cells in M.tuberculosis exposed γ Interferon Release Assay negative populations in Uganda and South Africa 2299672
Abstract Introduction Mycobacterium tuberculosis (Mtb) remains a leading cause of death worldwide. IFNγ Release Assay (IGRA) is widely used to diagnose Mtb infection by measuring the IFNγ response to Mtb antigens. However, healthy IGRA- individuals with high Mtb exposure (“resisters”) have shown evidence of infection and make Mtb-specific responses that differ from IGRA+ individuals. Human CD4 T cells are critical in controlling Mtb. IFNγ-expressing Th1 cells are largely believed to be the major protective subset. Resisters’ negative response to IGRA suggests alternative protective mechanisms of CD4 T cells. This study aims to profile the antigen-specific CD4+ T cell responses in Mtb-exposed IGRA- individuals. Methods We performed TCR sequencing on Ugandan resisters and IGRA+ individuals. TCR repertoires were analyzed with GLIPH3 algorithm we recently developed to identify resister-specific TCRs. Mtb antigenic ligands were discovered by a new T cell epitope discovery platform. Antigen-specific CD4+ T cells were then isolated using peptide-MHC multimers covering the discovered antigenic peptide, and characterized by single-cell multi-omics and Flow Cytometry. Results We identified 24 TCR specificity groups uniquely enriched in resisters. Two ligand peptides were decoded from Mtb antigens Rv2140c and ESAT6. In a parallel South African cohort, in IGRA- individuals, we detected T cell responses to ESAT6, the antigen used in IGRA test, and a robust response to Rv2140c. Notably, Rv2140c-specific CD4 T cells were predominantly follicular helper cells (Tfh), which correlated with protection from Mtb in mice, whereas IGRA+ individuals showed primarily Th1 responses. Conclusion We identified a novel Mtb antigen associated with protection, highlighting its potential as vaccine candidate. ESAT6-specific responses in IGRA- individuals confirmed underlying Mtb infection, indicating the limitations of IGRA tests. The predominance of Tfh cells reveals new protective human T cell mechanism against Mtb beyond the classic Th1 response. Funding Source Bill & Melinda Gates Foundation Topic Categories Microbial, Parasitic, and Fungal Immunology (MPF)
Authors
- Jingyi Xie (ORCID: https://orcid.org/0000-0002-8959-4268)
- Harriet Mayanja‐Kizza (ORCID: https://orcid.org/0000-0002-9297-6208)
- Gerlinde Obermoser (ORCID: https://orcid.org/0000-0003-4349-5149)
- Rongyu Zhang (ORCID: https://orcid.org/0000-0001-5699-3943)
- Abel Kakuru (ORCID: https://orcid.org/0000-0001-9941-1309)
- Azam Mohsin (ORCID: https://orcid.org/0000-0003-0021-3244)
- Mark Davis
- Kenneth Musinguzi (ORCID: https://orcid.org/0000-0001-6890-8988)
- Chetan Seshadri (ORCID: https://orcid.org/0000-0003-2783-7540)
- Huang Huang (ORCID: https://orcid.org/0000-0002-8377-4823)
- Holden Maecker (ORCID: https://orcid.org/0000-0001-5389-0906)
- Thomas Scriba
- Prasanna Jagannathan
- Florian Bach (ORCID: https://orcid.org/0000-0002-0126-5516)
- Ryan Furuichi Fong (ORCID: https://orcid.org/0009-0008-1320-0892)
- Vamsee Mallajosyula
- Meng Sun
- Deborah Cross
- W Henry Boom
- James Heath
- Fei Gao
- Chunlin Wang
Institutions
- University of Washington (US)
- TuBerculosis Vaccine Initiative (NL)
- Institute for Systems Biology (US)
- South African Tuberculosis Vaccine Initiative (ZA)
- Infectious Diseases Research Collaboration (UG)
- Case Western Reserve University (US)
- Makerere University (UG)
- Stanford University (US)
Publication Details
- Journal
- The Journal of Immunology
- Published
- 2026-07-28
- DOI
- https://doi.org/10.1093/jimmun/vkag141.1194
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00